Business
MedMira CEO Awarded Honorary Doctor of Science by Acadia University
HALIFAX , Aug. 21, 2013 /CNW/ - Acadia University, in Wolfville, Nova Scotia has awarded...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\nHALIFAX, Aug. 21, 2013 /CNW/ - Acadia University, in Wolfville, Nova\n Scotia has awarded an Honorary Doctor of Science to Hermes Chan, CEO\n and Co-Founder of MedMira Inc.  Mr. Chan took part in the celebrations\n for the 100th Anniversary of the Chemistry Department at Acadia University last week.\n\n\n\"On behalf of the Company's Board of Directors, I congratulate Hermes on\n being selected for this honor by Acadia University's Chemistry\n Department, where the vision for MedMira was born,\" said Markus Meile,\n Director.  \"This recognition is a testament to his personal and\n professional accomplishments as a scientist and a business leader, the\n co-creator of MedMira's patented rapid diagnostic technology, and the\n driving force behind the Company's validation by top tier healthcare\n regulators and care providers around the globe.\"\n\n\nDuring his time as a student in Acadia University's Chemistry\n Department, Mr. Chan, along with co-founder, Carlina Hui, worked\n together to cultivate the innovation and inspiration behind MedMira's\n award winning, patented rapid flow-through technology.  In 1993 they\n established MedMira to further develop and commercialize this\n technology and rapid testing solutions for HIV, Hepatitis, Syphilis, H.\n Pylori and other infectious diseases.  Today the Company is recognized\n around the world by leading healthcare providers, governments, and\n international organizations for its unique diagnostic platform and its\n high quality rapid tests which have achieved Health Canada, United\n States Food & Drug Administration, and China State Food and Drug\n Administration approvals.  The Company continues to operate in Nova\n Scotia, where its corporate headquarters and ISO, cGMP research and\n manufacturing facilities are located.\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of flow-through rapid\n diagnostics. The Company's tests provide hospitals, labs, clinics and\n individuals with reliable, rapid diagnosis for diseases such as HIV and\n hepatitis C in just three minutes. The Company's tests are sold under\n the Reveal®, Multiplo™ and Miriad brands in global markets. MedMira's\n rapid flow-through HIV test is the only one in the world to achieve\n regulatory approvals in Canada, the United States, China and the\n ...